(Q40334689)

English

Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges

scientific article published on 15 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges (English)

1 reference

Europe PubMed Central

19 September 2017

quality control

0 references

author name string

Steven D Brown

1

1 reference

Europe PubMed Central

19 September 2017

Maria M Traczewski

2

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

15 March 2010

1 reference

Europe PubMed Central

19 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

19 September 2017

54

1 reference

Europe PubMed Central

19 September 2017

5

1 reference

Europe PubMed Central

19 September 2017

2063-2069

1 reference

Europe PubMed Central

19 September 2017

In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

22 September 2017

Setting and revising antibacterial susceptibility breakpoints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

22 September 2017

In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

25 September 2017

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

15 June 2018

Modification of the error-rate bounded classification scheme for use with two MIC break points

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

15 June 2018

In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863606

20 August 2018

Identifiers

10.1128/AAC.01569-09

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40334689&oldid=2083860058"